INTELLIGENT VECTOR SOLUTIONS
DEAD

Serial Number

97112092

Owner

iVexSol Inc.

Attorney

Paul C. Llewellyn

Filing Date

Nov 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INTELLIGENT VECTOR SOLUTIONS Trademark

Serial Number: 97112092

INTELLIGENT VECTOR SOLUTIONS is a trademark filed by iVexSol Inc. on November 6, 2021. The trademark is classified under Class 1 (Chemicals). The application is currently no longer active.

Owner Contact Info

iVexSol Inc. (17 trademarks)

20 Maguire Road
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

November 6, 2021

Registration Date

Not Registered

Published for Opposition

November 8, 2022

Goods & Services

Biological materials being viral vectors for scientific and industrial use and for use in the manufacture and development of pharmaceutical and biopharmaceutical preparations; biological preparations for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds, for scientific and general industrial manufacturing use; Viruses, viral vectors and viral constructs being biological preparations for scientific and industrial use; Cells and biological membranes being a biological preparation for scientific and industrial use; Carriers for biologically active compounds, namely, chemical and biological preparations for use in the delivery of biologically active compounds for use in industry and the manufacture of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Chemical preparations for scientific and industrial use; Biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Cells and biological membranes being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines; Viruses, viral vectors being vector viruses and viral constructs being biological preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals and vaccines

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 4, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 4, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 26, 2025 EX4G
SOU EXTENSION 4 FILED
Dec 18, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 18, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 12, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 28, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 28, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 28, 2024 EEXT
CORRECTED NOA E-MAILED
Feb 22, 2024 NOAC
DIVISIONAL PROCESSING COMPLETE
Feb 21, 2024 DPCC
DIVISIONAL REQUEST RECEIVED
Feb 7, 2024 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Feb 7, 2024 ERTD
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Dec 27, 2023 UNTD
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 22, 2023 AITU
TEAS REQUEST TO DIVIDE RECEIVED
Dec 20, 2023 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 19, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 15, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 15, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 15, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 8, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 8, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 5, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 5, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 5, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 5, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 18, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2021 NWOS
NEW APPLICATION ENTERED
Nov 10, 2021 NWAP